Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase EARLY_PHASE1 1Phase 3 1Phase 2 1Phase 1 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Lymphoid 1

Conditions

Rare Diseases 1Neoplasm, Residual 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Genetic Predisposition to Disease 1

Interventions

Exercise 440Blood Specimen Collection 334Standard of Care 325Magnetic Resonance Spectroscopy 259Radiotherapy 255Surveys and Questionnaires 246Radiosurgery 245Methods 231Educational Status 231Early Intervention, Educational 219Interviews as Topic 149Practice Guidelines as Topic 147Biopsy 145Surgical Procedures, Operative 135Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 111Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 96Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Specimen Handling 82Radiotherapy, Intensity-Modulated 79Colonoscopy 79Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Interventional × High-Throughput Nucleotide Sequencing × Clear all
NCT06060184 2023-09-29

IonGER

University Hospital Tuebingen

Phase NA Not yet recruiting
500 enrolled

Genetic Predisposition to Disease, Rare Diseases

NCT02339805 2017-07-07

LymphoSeq

Centre Henri Becquerel

Phase NA Completed
30 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Neoplasm, Residual

NCT02420405 2017-02-16

Mutation Detection of EBUS-TBNA Specimens Using NGS

Shanghai Chest Hospital

Phase NA Completed
78 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡